The post CME Group May Offer 24/7 Trading for Bitcoin and Ethereum Futures and Options, Pending Regulatory Review appeared com. ‘+ 2 “+ ‘ ‘+ ‘ Advanced Platform. Real Opportunities.’+ ‘Access deep liquidity, fast execution, and powerful order types. Start today.’+ ‘ ‘+ 3 “+ ‘ ‘+ ‘ Make Every Move Count’+ ‘From spot to advanced trading tools, unlock a professional-grade experience in minutes.’+ ‘ ‘+ 4 “+ ‘ ‘+ ‘ Smart Tools for Serious Traders’+ ‘Set precise entries, manage risk, and act faster with pro features. Join now.’+ ‘ ‘+ 5 “+ ‘ ‘+ ‘ Speed, Depth, Control’+ ‘Tap into high-performance trading with robust charting and order execution.’+ ‘ ‘+ 6 “+ ‘ ‘+ ‘ Built for Professionals’+ ‘Leverage advanced analytics and a wide selection of assets. Get started now.’+ ‘ ‘+ 7 “+ ‘ ‘+ ‘ Precision Trading, Simplified’+ ‘Powerful charts, alerts, and order controls designed to help you execute with confidence.’+ ‘ ‘+ 8 “+ ‘ ‘+ ‘ Secure. Efficient. Professional.’+ ‘Experience a reliable environment to trade the markets your wayanytime.’+ ‘ ‘+ ]; var adplace = document. getElementById(“ads-binance”); if (adplace) { // Persist & rotate creatives per session var sessIndex = parseInt(sessionStorage. getItem(“adsindexProEx”), 10); var idx = Number. isInteger(sessIndex) ? sessIndex : Math. floor(Math. random * adscodesPro. length); adplace. innerHTML = adscodesPro[idx]; // Cycle next index var next = (idx === adscodesPro. length 1) ? 0 : idx + 1; sessionStorage. setItem(“adsindexProEx”, next); } }); CME Group will offer roundtheclock trading for its cryptocurrency futures and options in early 2026, pending regulatory review. The change extends trading to 24/7 for Bitcoin and Ethereum products, adds Solana and XRP options in October, and aims to improve risk management for clients. CME to open crypto products 24/7 in early 2026 (pending review) Solana and XRP options launch expected on Oct. 13; weekly twohour maintenance remains. ‘+ 2 “+ ‘. Continue reading CME Group May Offer 24/7 Trading for Bitcoin and Ethereum Futures and Options, Pending Regulatory Review→
